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Abstract
The integral membrane protein 2a (Itm2a) is one of the BRICHOS domain-containing proteins and is structurally related to
Itm2b and Itm2c. It is expressed preferentially in the T lineage among hematopoietic cells and is induced by MHC-mediated
positive selection. However, its transcriptional regulation and function are poorly understood. Here we showed Itm2a to be
a target gene of GATA-3, a T cell-specific transcription factor. Deficiency of Itm2a had little impact on the development and
function of polyclonal T cells but resulted in a partial defect in the development of thymocytes bearing a MHC class I-
restricted TCR, OT-I. In addition, Itm2a-deficient mice displayed an attenuated T helper cell-dependent immune response in
vivo. We further demonstrated that Itm2b but not Itm2c was also expressed in T cells, and was induced upon activation,
albeit following a kinetic different from that of Itm2a. Thus, functional redundancy between Itm2a and Itm2b may explain
the minimal phenotype of Itm2a deficiency.
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Introduction
GATA-3 is the third member of the GATA family of
transcription factors [1]. Among hematopoietic cells, GATA-3 is
expressed nearly exclusively in the T lineage, and is critical for the
development of CD4
+ T helper (Th) cells [2], the differentiation of
T helper type 2 (Th2) cells [3,4], the function of regulatory T
(Treg) cells [5,6], and the activation/homeostasis of CD8
+
cytolytic T (Tc) cells [7,8]. However, it is still not fully understood
how GATA-3 executes its function. Several GATA-3 targets genes
have been identified. For example, GATA-3 directly regulates the
expression of Th-POK (encoded by Zbtb7b) [9], a transcription
factor that is also essential for the development of CD4
+ T cells
[10,11]. However, reconstitution of Th-POK was unable to rescue
the development of GATA-3-deficient CD4
+ T cells, suggesting
the presence of additional GATA-3 target genes in mediating its
function.
Itm2a is a type II transmembrane protein and contains 263
amino acid residues [12]. It is highly conserved between human
and mouse. Itm2a belongs to the Type II Integral Membrane
protein (Itm2) family, which also includes Itm2b and Itm2c [13].
Members of this protein family contain a BRICHOS domain,
which possesses chaperone activity [14], a transmembrane domain
at the N-terminus, and a furin cleavage site at the C-terminus.
Among the Itm2 family members, Itm2b is the most extensively
studied protein. The ectodomain of Itm2b can undergo at least
three steps of protease-mediated cleavage [15,16]. The first
cleavage occurs at the C-terminus and is mediated by furin. The
remaining Itm2b protein can be further cleaved by ADAM10
protease, releasing the C-terminal half, including the BRICHOS
domain, into extracellular compartments. The remaining N-
terminal half of Itm2b can then undergo regulated intramembrane
proteolysis mediated by signal peptide peptidase (SPP) 2a and 2b.
This intramembrane proteolytic event yields an intracellular
domain (ICD) and a secreted low molecular weight peptide.
Two types of mutation of Itm2b have been link to familial British
Dementia (FBD) and familial Danish Dementia (FDD) [17,18].
Both mutations result in the addition of 10 amino acid residues to
the furin-cleaved C-terminal peptide, which accumulates in CNS
forming the pathogenic plaques found in these patients. However,
how the addition of 10 amino acids leads to the development of
dementia is still unclear. Given the high degree of similarity in
protein structure among itm2 proteins, it is very likely that such
protease-mediated cleavages also occur on Itm2a. Evidence
supporting this notion however is still lacking.
Like GATA-3, Itm2a is also preferentially expressed in cells of
the T lineage among hematopoietic cells according to the Immgen
database (http://www.immgen.org). Thus far, there are only a
handful of published studies providing clues regarding the role of
Itm2a in T cells. Itm2a was identified as a gene that was induced
by MHC-mediated positive selection of double positive (DP)
thymocytes [19]. Peripheral naı ¨ve Th and Tc cells expressed a low
level of Itm2a, which was transiently induced when T cells were
stimulated with concanavalin A. Three recent transcription profile
studies independently found that the expression of Itm2a was
significantly lower in Treg cells than in effector Th cells [20-22].
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regulated genes in Treg cells and suggested that its expression was
suppressed by Foxp3, the master transcription factor of Treg cells
[21]. In addition, Itm2a was one of approximately 15 genes
including CD3, Lck, and TCRb, preferentially expressed in
pediatric T-ALL [23]. Lately, Itm2a was linked to Graves’ disease
in a staged genome-wide association study [24], further strength-
ening its role in the immune system.
In this report, we show that the expression of Itm2a was reduced
in GATA-3-deficient thymocytes and that Itm2a is transactivated
by GATA-3. Although polyclonal thymocytes of Itm2a-deficient
mice develop normally, Itm2a-deficient mice display a partial
defect in the development of thymocytes bearing the MHC class I-
restricted OT-I TCR but not the MHC class II-restricted OT-II
TCR. Surprisingly, deficiency of Itm2a has little impact on the
differentiation, activation, and function of T cells in vitro.
However, Itm2a KO mice are not as efficient as wild type mice
in mounting humoral immune responses against a model Th cell-
dependent antigen. We further show that Itm2b was also




The targeting construct of Itm2a was created through a
recombineering-based method. The detailed strategy will be
provided upon request. The targeting construct was then
introduced into 129xB6 hybrid ES cells by inGenious Targeting
Laboratory (Stony Brook, NY) to create floxed Itm2a mice. The
Itm2a gene in the floxed allele was then deleted with EIIa-cre (The
Jackson Laboratories) to create Itm2a-deficient mice, which were
backcrossed to C57BL/6 mice for five generations before use. OT-
I and OT-II mice (The Jackson Laboratories) were also crossed
with Itm2a-deficient mice. Male or female mice aged 4–12 weeks
were used. In all experiments, littermates were used as controls.
Ethics statement
All animals were housed under specific pathogen-free condi-
tions, and experiments were performed in accordance with the
institutional guidelines for animal care under a protocol (#07-017)
approved by the Institutional Animal Care and Use Committee
(IACUC) of Dana-Farber Cancer Institute.
Activation of T cells and in vitro differentiation of Th cells
Total cells were collected from spleens and activated with plate
bound anti-CD3 (ranging from 0.5 mg/ml to 1 mg/ml), OT-II
peptide (OVA 323-339), or OT-I peptide (SIINFEKL, OVA 257-
264) at different concentrations. After 3 days, cells were collected
and stained with surface markers. The supernatant was collected
for cytokine analysis by ELISA. For in vitro differentiation of Th
cells, CD4
+ T cells were purified from spleens and lymph nodes by
magnetic cell sorting (Miltenyi Biotec). The cells were stimulated
with 1 mg/ml plate-bound anti-CD3 and 2 mg/ml soluble anti-
CD28 under Th1 (3 ng/ml IL-12 plus 10 mg/ml anti-IL-4) or Th2
(10 ng/ml IL-4 plus 10 mg/ml anti-IFN-c) conditions. For Th17
differentiation, total CD4
+ cells were cultured in the presence of
WT irradiated splenocytes (1:3 ratio) and 3 ng/ml TGF-b1 and
20 ng/ml IL-6. Recombinant human IL-2 (100 U/ml) was added
after 24 h, and the cells were expanded in complete medium
containing IL-2. On day 7, the cells were restimulated with 50 ng/
ml PMA and 1 mM ionomycin. The cytokine production was
examined by intracellular cytokine staining.
FACS analysis and antibodies
The following clones of antibody were purchased from
Biolegend and used for cell surface staining: CD4 (RM4-5), CD8
(53-6.7), TCRb (H57-597), B220 (RA3-6B2), CD69 (H1.2F3),
CD25 (PC61), Vb5 (MR9-4), IgM (RMM-1), IgD (11-26c.2a),
CD21 (7E9), CD23 (B3B4). Flow cytometry was performed on a
FACSCanto or FACSCanto II and analyzed with FlowJo
software.
Western blot and antibodies
In each sample, 1610
6 CD4
+ cells were lysed in freshly
prepared radioimmumoprecipitation assay buffer. Cell lysate was
separated from debris by centrifugation at 12,000 rpm for 10 min.
Lysate was loaded onto 12% polyacrylamide gels and transferred
onto PVDF membrane (Polyscreen; Perkin Elmer). The mem-
brane was subsequently blocked in 5% milk and probed with
Itm2a antibody. The rabbit anti-human Itm2a antibody was
generated by using Itm2a extracellular domain as an immunogen.
Proteins were visualized using an ECL kit (PerkinElmer).
Quantitative RNA analysis
Total RNA was purified using a Trizol Plus kit (Invitrogen).
First-strand cDNA synthesis was performed on 200ng of total
RNA using the QuantiTect Reverse Transcription kit (QIAGEN).
Gene expression levels were determined by real-time PCR analysis
Figure 1. Itm2a is a target gene of GATA-3. A. Total RNA was
prepared from DP thymocytes of WT and G3KO mice. The transcript
level of Itm2a was quantified with real time PCR. The transcript level
was then normalized against that of Actb. The data shown are means
and standard deviation of three experiments. B. A schematic diagram of
the 2 kb promoter of Itm2a. The location and sequence of the
conserved and mutated GATA sites are shown. The black boxes
represent exon of Itm2a. The thick arrow marks the transcription start
site. C. M12 cells were transfected with the indicated luciferase reporter
constructs along with a GATA-3 expression vector or an empty vector.
The relative luciferase activity was calculated as described in the
Materials and Methods. The data shown are means and standard
deviations of three independent experiments.
doi:10.1371/journal.pone.0096535.g001
Itm2a and T Cells
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the manufacturer’s protocol (Stratagene) on a MX-3000P appa-
ratus (Stratagene) using the following cycling conditions: denatur-
ation at 95uC for 30 s, annealing at 56uC for 60 s, and extension
at 72uC for 30 s. Primer sets were designed using the Primer3 web
utility. Levels of mRNA were adjusted for differences in actb
(encoding beta-actin) expression. The following primers are used:
Itm2a 59-CGCACTGTCCGAGCTCAAAT-3’ and 5’-
CATCTCCCAGATGAGCCATCC-3’; Itm2b 5’-GAAGGT-
GACGTTCAACTCGG-3’ and 5’- CTCTGTCCAACCG-
GAACCAC-3’; Itm2c 5’-GTCGCCATCAAGGCTGATAAA-3’




Sandwich ELISA was performed using the following monoclo-
nal antibody pairs (BD Biosciences): anti–IL-2 (JES6-1A12)/
Figure 2. Deficiency of Itm2a has little impact on the differentiation of immune cells. A. Generation of Itm2a-deficient mice. Schematic
diagrams of Itm2a gene (top), the targeting construct (middle), and deleted allele (bottom) are shown. Exons are represented with gray boxes and
numbered. Regions for homologous recombination are marked with dashed lines. Neo and TK stand for neomycin cassette and thymidine kinase. B.T
cells were purified from control (WT) and two Itm2aKO mice and stimulated with anti-CD3 for 72 hours. Cell extract from the stimulated cells was
probed with anti-Itm2a and anti-Hsp90. C. Thymocytes of WT and Itm2aKO mice were enumerated, and the means and standard deviations are
shown in the left panel. D&E . The thymocytes were also stained with anti-CD4/anti-CD8 (D) and anti- a/b TCR, and TCR
high cells were further stained
with antibodies against various Vb chains indicated in E. F. The thymocytes were stained with anti-CD4/anti-Foxp3 and anti-TCR/NK1.1. G.
Splenocytes and lymph node cells of WT and Itm2aKO mice were stained with anti-CD4 and anti-CD8. H. The splenocytes were also stained with anti-
TCR/anti-B220. B220
+ cells were then further separated by anti-IgM/anti-IgD staining. The data shown in D–H are representative FACS plots of at least
three independent experiments.
doi:10.1371/journal.pone.0096535.g002
Itm2a and T Cells
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anti–IFN-c (XMG1.2).
Plasmid, transfection, and luciferase assay
An approximately 2 kb genomic fragment containing +28 to -
1964 in relation to the transcriptional start site of the murine Itm2a
gene was amplified and cloned into the BglII site of the PGL2-
Basic (Promega) to create Itm2a-Luc. The IL-13-Luc and
pcDNA3-GATA3 were previous reported [25]. In all luciferase
assays, murine M12 B cells were transfected with 10 mgo f
luciferase reporter, 5 mg of pcDNA3 vector, and 5 mg pTK-
Renilla with BIORAD GENE PULSER II set at 280 V and
0.975 F. Luciferase activity was determined in duplicate with
Dual-Luciferase Reporter Assay System (Promega, Madison, WI).
The firefly luciferase activity obtained from each sample was
normalized against the renilla luciferase activity from the same
sample.
CTL killing
CTL killing assay was adapted from a published protocol [26].
Briefly, total splenocytes from WT and KO mice were cultured
with irradiated splenocytes from Balb/c (H-2
d) mice for 7 days and
viable cells were collected as effector cells. EL4 (H-2
b) or P815 (H-
2
d) target cells were label with CellTrack Far Red DDAO-SE
(Molecular Probes Eugene, OR) at 37uC for 10 min. Effector and
target cells (1610
5) were mix at different ratio and incubated at
37uC, 5% CO2 in a humidified incubator for 4 hours. Cells were
collected, fixed and stained with anti-activated caspase-3 antibody
(BD Bioscience CA).
In vivo immunization and Th recall response
Mice were immunized with 20 mg trinitrophenyl-conjugated
keyhole limpet hemocyanin KLH (TNP-KLH) (Biosearch Tech-
nologies, Novato, CA) emulsified in complete Freund adjuvant
(CFA) through a subcutaneous injection. Immunized mice were
sacrificed two weeks later. For recall response, 1610
6 lymph node
cells were stimulated with 20 mg/ml TNP-KLH for 3 days,
Figure 3. Deficiency of Itm2a has no impact on the function of peripheral T cells. A & B. Splenocytes of WT and Itm2aKO mice were
stimulated with anti-CD28 (2 mg/ml) and indicated amount of anti-CD3 for three days. The expression of CD25 by CD4
+ and CD8
+ T cells was
examined with FACS and is shown in A. The concentration of IL-2 and IFN-c in the supernatant of stimulated cells was quantified with ELISA. The
means and standard deviations of three independent experiments are shown in B. C. Naive Th cells of WT and Itm2aKO mice were differentiated in
vitro under Th1, Th2, and Th17 polarization conditions, and re-stimulated with PMA/ionomycin. The production of indicated cytokines was examined
with intracellular cytokine staining. Representative FACS plots are shown. D. CTL activity of WT and Itm2aKO CD8
+ T cells was examined according to
the protocol described in the Material and Methods. The data shown are means and standard deviations of three independent experiments.
doi:10.1371/journal.pone.0096535.g003
Itm2a and T Cells
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by ELISA.
Results and Discussion
Itm2a is a target gene of GATA-3 in thymocytes
To identify downstream targets of GATA-3 in thymocytes, we
conducted gene chip analyses comparing the transcription profile
between GATA-3-deficient (G3KO) and wild type DP thymo-
cytes. We then focused on genes that were differentially expressed
and have poorly characterized function. Among those genes,
Itm2a was one of the most downregulated in G3KO DP cells. The
differential expression of Itm2a was subsequently verified with real
time PCR, confirming that Itm2a is a GATA-3 target gene in
thymocytes (Figure 1A). We then examined the genomic sequence
of mouse Itm2a with rVista 2.0 program (http://rvista.dcode.org)
and found that the promoter region of Itm2a contains one
consensus GATA binding site located at -222 to -228 relative to
the transcriptional start site (Figure 1B). This site is also conserved
in human ITM2A gene. In addition, overexpression of GATA-3 in
M12 cells, which do not express GATA-3, transactivated a 2kb
Itm2a promoter reporter, encompassing the conserved GATA site,
as efficiently as an IL-13 promoter (Figure 1C), a known target of
GATA-3. However, mutation of the putative GATA-3 site only
modestly attenuated the transactivation by GATA-3 (Figure 1C),
suggesting the presence of additional GATA sites. Overall, these
data strongly suggest that Itm2a is a target of GATA-3 and
provides an explanation for its T cell-specific expression among
hematopoietic cells.
Generation of Itm2a-deficient mice
The expression of Itm2a is induced in activated T cells [19]. To
investigate the function of Itm2a in T cells, we transduced
activated Th cells with a retrovirus expressing Itm2a. However, we
found that overexpression of Itm2a had little impact on the
activation, survival, and cytokine production of Th cells (data not
shown). Therefore we set out to generate Itm2a-deficient
(Itm2aKO) mice. We inserted a neomycin cassette and two loxp
sites into the Itm2a allele (Figure 2A). We then deleted the Itm2a
gene in germline with the EII-a Cre transgene. Itm2aKO mice
were born according to Mendelian ratios and had normal
development and growth up to 6 months of age (data not shown).
T cells obtained from Itm2aKO mice contained no detectable
Itm2a protein (Figure 2B), confirming the complete deletion of the
Itm2a gene. This lack of developmental defect is consistent with the
results of a recent publication [27], in which an independently
generated Itm2a-deficient mouse strain was studied.
T cell development is normal in Itm2aKO mice
Although Itm2a transgenic mice have a subtle aberration in the
expression of CD8 [19], we found that deficiency of Itm2a had no
apparent impact on the development of thymocytes. The total
number of thymocytes and the percentage of CD4 single positive
(SP), CD8SP and CD4
+ CD8
+ cells were very comparable
between WT and Itm2aKO mice (Figure 2C and 2D). In
addition, the mean fluorescence intensity of CD4, CD8, HSA,
TCR, and Qa2 was normal in Itm2aKO thymocytes (data not
shown). We further investigated the TCR repertoire with
antibodies against various Vb chains and found no apparent
difference between WT and Itm2aKO mice (Figure 2E). The
numbers of Foxp3
+ Treg cells and natural killer T (NKT) cells
were also normal (Figure 2F). Similarly, there was no detectable
difference in the number and CD4/CD8 ratio of T cells in
peripheral lymphoid organs (Figure 2G). Furthermore, the
development and expression of various differentiation markers of
other immune cells including B cells and myeloid cells were
unaltered in the absence of Itm2a (Figure 2H and data not shown).
Normal activation of Itm2aKO T cells
We then examined if loss of Itm2a would affect T cell activation.
We stimulated splenocytes with escalating doses of anti-CD3 for 3
days. The induction of activation markers including CD25 and
CD69, and cell recovery were comparable between WT and
Itm2aKO CD4
+ and CD8
+ T cells (Figure 3A and data not
shown). There was also no difference in the production of IL-2 and
IFN-c (Figure 3B). In addition, Itm2aKO Th cells differentiated
normally into Th1, Th2, and Th17 cells in vitro (Figure 3C). We
also examined CTL activity against MHC mismatched targets of
Itm2aKO CD8
+ T cells and found no apparent defect (Figure 3D).
Figure 4. Deficiency of Itm2a does not affect the selection and
activation of OT-II T cells. A. Thymocytes of WT/OT-II and KO/OT-II
mice were stained with anti-CD4, anti-CD8, and anti-Vb5. Representa-
tive FACS plots are shown. The means and standard deviations of total
thymocytes and CD4
+Vb5
+ thymocytes from three experiments are
shown in the left panels. B. Splenocytes of WT/OT-II and KO/OT-II mice
were stimulated with ovalbumin peptides at indicated concentration
for 3 days. The percentages of live cells were determined based on the
FSC/SSC gate and are shown. The cells were also stained with anti-CD25
and anti-CD69. Representative FACS plots are shown.
doi:10.1371/journal.pone.0096535.g004
Itm2a and T Cells
PLOS ONE | www.plosone.org 5 May 2014 | Volume 9 | Issue 5 | e96535Figure 5. Itm2a regulates the thymic development but not the activation of OT-I cells. A. Thymocytes of WT/OT-I and KO/OT-I mice were
stained with anti-Vb5, anti-a/b TCR, anti-CD4, and anti-CD8, and. representative TCR/Vb5 FACS plots are shown in the left column. The CD4/CD8 FACS
plots of TCR
+Vb5
+ cells are shown in the right column. The DP, post-selected CD4+CD8dull (PS), and CD8SP populations of TCR
+Vb5
+ cells are gated.
B. The numbers of DP, PS, and CD8SP Vb5
+ cells were enumerated from three pairs of mice. The means and standard deviations are shown. Statistical
analysis was performed with Student’s t tests. C. The histograms of CD69 and CD5 of indicated Vb5
+ thymocytes of WT/OT-I and KO/OT-I mice are
overlaid and shown. D. Splenocytes and lymph nodes cells of WT/OT-I and KO/OT-I mice were stained with anti-Vb5 and anti-CD8. Representative
CD8/Vb5 FACS plots and the absolute numbers of CD8
+Vb5
+ cells are shown. E. Splenocytes of WT/OT-I and KO/OT-I mice were stimulated with
ovalbumin peptides at the indicated concentrations for 3 days. The percentages of live cells were determined based on the FSC/SSC gate and are
Itm2a and T Cells
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and function of polyclonal T cells.
Itm2a regulates the development of OT-I but not OT-II
thymocytes
To address whether Itm2a deficiency might affect the develop-
ment of monoclonal thymocytes, we first crossed Itm2aKO mice
with OT-II TCR transgenic mice, which bear an MHC class II-
restricted TCR recognizing a peptide derived from ovalbumin.
Introduction of the OT-II TCR comparably increased the
percentage and number of CD4SP thymocytes cells in both WT
and Itm2aKO mice (Figure 4A, upper row). The number of
mature OT-II CD4
+ thymocytes was normal in the absence of
Itm2a (Figure 4A, lower row). We further stimulated WT/OT-II
and Itm2aKO/OT-II splenocytes with the cognate ovalbumin
peptide and found no difference in the expansion and activation of
OT-II CD4
+T cells (Figure 4B). Thus, deficiency of Itm2a very
likely does not affect MHC class II-mediated selection and
antigen-specific activation of CD4
+ T cells.
We then introduced the OT-I TCR transgene, a MHC class I-
restricted TCR, into Itm2aKO mice. In OT-I mice, nearly all
TCR
+ cells are also positive for Vb5 (Figure 5A). Interestingly, we
found that deficiency of Itm2a led to an approximately 50%
reduction in the number of mature Vb5
+CD8
+SP OT-I thymo-
cytes (Figure 5A and 5B). One possible explanation for the
reduction in the number of mature OT-I thymocytes in the
absence of Itm2a is that Itm2a is required for the optimal positive
selection. Upon positive selection by MHC, DP thymocytes up-
regulate CD69 and CD5, and become CD4
+CD8
dull before
transiting into SP cells. However, the induction/expression of




thymocytes was very comparable between WT/OT-I and
Itm2aKO/OT-I mice (Figure 5C). In addition, the absolute
shown. The cells were also stained with anti-CD25 and anti-CD69. Representative FACS plots are shown.
doi:10.1371/journal.pone.0096535.g005
Figure 6. Impaired immune response to Th cell-dependent antigens in the absence of Itm2a. WT (N=8) and Itm2aKO (N=7) mice were
immunized with TNP-KLH in CFA at tail base. Two weeks after the immunization, the level of TNP-specific IgG was quantified with ELISA (A). The
percentage of plasma cells (CD138
+B220
dull) among splenocytes was calculated (B). T cells of draining (inguinal) and non-draining (axillary) lymph
nodes were further stained with anti-ICOS/anti-PD-1. ICOS
+PD-1
+ Tfh cells were gated (C). The means and standard deviations of the percentage of
Tfh among lymph node Th cells are shown in the right panel of C. Draining LN cells were restimulated with TNP-KLH for 24 hours. The concentration
of IFN-c and IL-2 in the supernatant of the stimulated cells was quantified with ELISA (D). Statistical analyses were performed with unpaired Student’s
t tests.
doi:10.1371/journal.pone.0096535.g006
Itm2a and T Cells
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+ OT-I cells was normal in the absence of Itm2a
until the CD8SP stage when an approximately 50% reduction in
the number was observed (Figure 5B). This data strongly suggest
that deficiency of Itm2a has little impact on MHC-mediated
selection of OT-I cells and that Itm2a deficiency results in a partial
defect in the transition from CD4
+CD8
dull to CD8SP stage. The
cause of this defect is still unclear but is unlikely due to enhanced
apoptosis of CD8SP cells because there was no apparent difference
in the level of Annexin V and 7-AAD between WT/OT-I and
Itm2aKO/OT-I CD8SP thymocytes (data not shown)
Despite the reduction in number, the subsequent maturation of
the Itm2aKO/OT-I CD8SP thymocytes appeared to be normal
based on the down-regulation of HSA and the induction of Qa2
(data not shown). In addition, deficiency of Itm2a did not affect the
number of OT-I T cells in peripheral lymphoid organs (Figure 5D);
and stimulation of WT and Itm2aKO OT-I splenocytes with the
cognate peptide resulted in comparable cell expansion and
induction of activation markers (Figure 5E).
Attenuated T cell-dependent humoral responses in
Itm2aKO mice
We subsequently asked whether lack of Itm2a would affect T
cell-dependent immune responses in vivo. We immunized mice
with CFA-emulsified TNP-KLH and found that immunized
Itm2aKO mice had less TNP-specific IgG in serum compared
to control mice (Figure 6A). Immunized Itm2aKO mice also had
fewer plasma cells in their spleens (Figure 6B). However, the
number of follicular helper T (Tfh) cells was normal in Itm2aKO
mice (Figure 6C). We then restimulated lymph node cells obtained
from immunized mice with TNP-KLH in vitro and found that the
production of IL-2 and IFN-c by the restimulated lymph node
cells was not affected by the absence of Itm2a (Figure 6D). It is
unclear how deficiency of Itm2a regulates the homeostasis of
plasma cells and the production of antigen-specific IgG. Given the
preferential expression of Itm2a in T cells, these defects are very
likely intrinsic to T cells. However, we cannot rule out the
possibility that Itm2a has a B cell-intrinsic role. Examining mice
deficient in Itm2a only in T or B cells will clarify this issue.
Possible functional redundancy among the members of
the itm2 family
Our data indicate that Itm2a is a target gene of GATA-3.
However, the phenotype of Itm2a deficiency was rather modest.
This modest phenotype raises the possibility that Itm2b and/or
Itm2c may compensate for the loss of Itm2a. We therefore
compared the expression of these three genes in thymocytes and
activated Th cells. We found that the transcript level of Itm2b was
almost 10 times higher than that of Itm2a in thymus and activated
T cells (Figure 7A). In contrast, the transcript of Itm2c was almost
undetectable. In agreement with the published data, the protein
level of Itm2a gradually increased in response to in vitro
stimulation and peaked at day 2 after stimulation (Figure 7B),
but quickly faded away after day 4. The level of Itm2b protein also
increased in activated T cells but peaked at day 3-4. Unlike Itm2a,
the level of Itm2b was maintained up to seven days after
stimulation. This result suggests that Itm2b very likely compen-
sates for the loss of Itm2a. Itm2b-deficient mice have been
generated, but their immune phenotype has never been reported.
It will of great interest to examine the development and function of
T cells in mice deficient in Itm2b or both Itm2a and Itm2b.
In summary, Itm2a is a target gene of GATA-3 in thymocytes. It
is required for the optimal development of OT-I thymocytes and
humoral responses to Th cell-dependent antigens. However, its
role in the adaptive immunity is rather modest probably due to
functional compensation from Itm2b, which is also highly
expressed in T cells. Thus, the combined function of Itm proteins
remains to be determined.
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